logo
Volume 13, Issue 1 (1-2026)                   jbrms 2026, 13(1): 12-23 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Korani F, Rezvani N, Sadeghi kalani B, Pakzad R, Asadollahi P. Colorectal Cancer and Lactobacillus plantarum: A qPCR-Based Study of FFPE Tissues. jbrms 2026; 13 (1) :12-23
URL: http://jbrms.medilam.ac.ir/article-1-979-en.html
Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran & Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran , asadolahi.p@gmail.com
Abstract:   (27 Views)
Introduction: Colorectal cancer (CRC) is a major global health issue. The gut microbiota has become an important factor in CRC development, with increased focus on microbes such as Lactobacillus plantarum. This study aimed to examine the presence and relative abundance (GAPDH-normalised copy number) of L. plantarum in colorectal tissues using a qPCR approach.
Materials & Methods: DNA was extracted from formalin-fixed paraffin-embedded (FFPE) tissues from three groups: tumour tissues from CRC patients (n = 50), matched adjacent normal tissues (n = 50), and normal tissues from individuals without CRC (n = 30). Species-specific primers targeting the groEL gene were used to measure L. plantarum, normalised against human GAPDH. Statistical analyses compared occurrence and levels across groups and assessed associations with age and sex.
Results:  Although bacterial load did not vary significantly across tumour, Adjacent, and Normal tissues, detection frequency was higher in tumour tissues (p = 0.0459). L. plantarum was also detected more often in individuals aged ≥60 (p = 0.0024). Subgroup analysis revealed higher loads in Normal tissues of older adults and females and lower abundance in Adjacent tissues of females.
Conclusion:  L. plantarum was detected more frequently in tumour tissues despite consistent bacterial loads, indicating possible persistence rather than growth. These findings highlight age-, sex-, and tissue-specific colonisation patterns and emphasise the need for further research on the tumour-associated ecology of beneficial microbes.
 
Full-Text [PDF 742 kb]   (5 Downloads)    
Type of Study: Research | Subject: Clinical microbiology
Received: 2025/05/31 | Accepted: 2025/08/26 | Published: 2026/01/4

References
1. Hu Y, Zhou P, Deng K, Zhou Y, Hu K. Targeting the gut microbiota: a new strategy for colorectal cancer treatment. J Transl Med. 2024;22(1):915. [DOI:10.1186/s12967-024-05671-02.]
2. Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol. 2018;7:1204. [DOI:10.3389/fmicb.2016.01204.]
3. Kim H-J, An J, Ha E-M. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells. J Microbiol. 2022;60(1):100–17. [DOI:10.1007/s12275-022-1495-1.]
4. Yue Y-C, Yang B-Y, Lu J, Zhang S-W, Liu L, Nassar K, et al. Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway. Microb Cell Fact. 2020;19:1–12. [DOI:10.1186/s12934-020-01424-2.]
5. Zinatizadeh N, Khalili F, Fallah P, Farid M, Geravand M, Yaslianifard S. Potential preventive effect of Lactobacillus acidophilus and Lactobacillus plantarum in patients with polyps or colorectal cancer. Arq Gastroenterol. 2018;55:407–11. [DOI:10.1590/S0004-2803.201800000-93.]
6. Zaharuddin L, Mokhtar NM, Muhammad Nawawi KN, Raja Ali RA. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol. 2019;19:1–8. [DOI:10.1186/s12876-019-1047-4.]
7. Wu Y, Zhuang J, Zhang Q, Zhao X, Chen G, Han S, et al. Aging characteristics of colorectal cancer based on gut microbiota. Cancer Medicine. 2023;12(17):17822–34. [DOI:10.1002/cam4.6327.]
8. Khodaverdi N, Zeighami H, Jalilvand A, Haghi F, Hesami N. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients. BMC cancer. 2021;21(1):1353. [DOI:10.1186/s12885-021-09141-z.]
9. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2018;19(11):1423–37. [DOI:10.1038/nm.3394.]
10. Gajewski TF, Schreiber H, Fu Y-X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2018;14(10):1014–22. [DOI:10.1038/ni.2703.]
11. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2019;8(3):171–84. [DOI:10.1038/nrmicro2297.]
12. van Bokhorst-van de Veen H, Abee T, Tempelaars M, Bron PA, Kleerebezem M, Marco ML. Short-and long-term adaptation to ethanol stress and its cross-protective consequences in Lactobacillus plantarum. Appl Environ Microbiol. 2019;77(15):5247–56. [DOI:10.1128/AEM.01857-10.]
13. Garrett WS. Cancer and the microbiota. Science. 2019;348(6230):80–6. [DOI:10.1126/science.aaa4972.]
14. Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2018;65(12):1973–80. []
15. O’Toole PW, Jeffery IB. Microbiome–health interactions in older people. Cell Mol Life Sci. 2018;75:119–2. [DOI:10.1136/gutjnl-2015-310101.]
16. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2018;339(6123):1084–8. [DOI:10.1126/science.1233521.]
17. Kwon H-K, Lee C-G, So J-S, Chae C-S, Hwang J-S, Sahoo A, et al. Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A. 2019;107(5):2159–64. [DOI:10.1073/pnas.0904055107.]
18. Liu Y, Alookaran JJ, Rhoads JM. Probiotics in autoimmune and inflammatory disorders. Nutrients. 2018;10(10):1537. [DOI:10.3390/nu10101537.]
19. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients23. Am J Clin Nutr. 2019;85(2):488–96. [DOI:10.1093/ajcn/85.2.488..]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.